Senior insider sale
Chief Executive Officer at NEWAMSTERDAM PHARMA CO N.V. — senior position signals high conviction
$410.9K
11.58K shares
What this filing means
DAVIDSON MICHAEL H. plans to sell 11.58K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $410.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/7/2026ACC: 0001974494-26-000023
DirectorOfficer· Chief Executive Officer
Since Mar 2026
11.58K
Shares to sell
$410.9K
Approx. market value
41.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of RSU Grant
RSU Vesting
1/6/2026
41.18KTotal acquired41.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/6/2026 | Vesting of RSU Grant RSU Vesting | 41.18K | — |
| Total | 41.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.58K
Market value
$410.9K
1/7/2026
Total
Units
11.58K
Value
$410.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/7/2026 | 11.58K | $410.9K | NASDAQ | Planned |
| Total | 11.58K | $410.9K | ||